Literature DB >> 27373527

Creating a lesion-specific "roadmap" for ambulatory care following surgery for complex congenital cardiac disease.

Gil Wernovsky1, Stacey L Lihn2, Melissa M Olen1.   

Abstract

Over the past 20 years, the successes of neonatal and infant surgery have resulted in dramatically changed demographics in ambulatory cardiology. These school-aged children and young adults have complex and, in some cases, previously unexpected cardiac and non-cardiac consequences of their surgical and/or transcatheter procedures. There is a growing need for additional cardiac and non-cardiac subspecialists, and coordination of care may be quite challenging. In contrast to hospital-based care, where inpatient care protocols are common, and perioperative expectations are more or less predictable for most children, ambulatory cardiologists have evolved strategies of care more or less independently, based on their education, training, experience, and individual styles, resulting in highly variable follow-up strategies. We have proposed a combination proactive-reactive collaborative model with a patient's primary cardiologist, primary-care provider, and subspecialists, along with the patient and their family. The goal is to help standardise data collection in the ambulatory setting, reduce patient and family anxiety, increase health literacy, measure and address the non-cardiac consequences of complex cardiac disease, and aid in the transition to self-care as an adult.

Entities:  

Keywords:  Ambulatory cardiology; CHD; cardiac surgery; guidelines

Mesh:

Year:  2016        PMID: 27373527     DOI: 10.1017/S1047951116000974

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  1 in total

1.  Biopsychosocial Predictors of Quality of Life Outcomes in Pediatric Congenital Heart Disease.

Authors:  Michelle M Ernst; Bradley S Marino; Amy Cassedy; Carrie Piazza-Waggoner; Rodney C Franklin; Katherine Brown; Jo Wray
Journal:  Pediatr Cardiol       Date:  2017-10-04       Impact factor: 1.655

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.